Complete Revascularization with Multivessel PCI for Myocardial Infarction
Shamir R. Mehta(Population Health Research Institute), John A. Cairns, Brandi Meeks(Population Health Research Institute), Roxana Mehran(Mount Sinai Hospital), Benjamin Wrigley(The Royal Wolverhampton NHS Trust), Sunil V. Rao(New York University), Kevin R. Bainey(Alberta Hospital Edmonton), Warren J. Cantor(University of Toronto), Shrikant I. Bangdiwala(Population Health Research Institute), Helen Nguyen(University of Washington), Robert F. Storey(University of Sheffield), Josep Rodés‐Cabau(Institut universitaire de cardiologie et de pneumologie de Québec), Goran Stanković(University of Belgrade), Laurent J. Feldman(MACOM (United States)), Giuseppe Di Pasquale(Population Health Research Institute), Shahar Lavi(London Health Sciences Centre), Saško Kedev, Gianluca Campo(Azienda Unità Sanitaria Locale di Ferrara), David Wood(Valve (United States)), Juliet Nakamya(Population Health Research Institute), Álvaro Avezum(Sociedade de Nefrologia do Estado de São Paulo), Laura Mauri(Brigham and Women's Hospital), Raúl Moreno(Hospital Universitario La Paz), Natalia Pinilla‐Echeverri(Population Health Research Institute), José López-Sendón(Hospital Universitario La Paz), Richard Oliver(Population Health Research Institute), Tej Sheth(McMaster University), David P. Faxon(Memorial Hermann), Andrew G.C. Sutton(Population Health Research Institute), Robert C. Welsh(University of Alberta), Jia Wang(Shantou University), Philippe Gabríel Steg(Mount Sinai Hospital)
Cited by 926
Related Papers
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2009|7.1k
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation
|European Heart Journal|2012|6.8k
Clinical End Points in Coronary Stent Trials
|Circulation|2007|5.4k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k